376 related articles for article (PubMed ID: 22612757)
21. ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment.
Haubitz M
Vasa; 2007 May; 36(2):81-9. PubMed ID: 17708098
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobins].
Mouthon L
Rev Med Interne; 1999; 20 Suppl 4():431s-435s. PubMed ID: 10522318
[TBL] [Abstract][Full Text] [Related]
23. How to improve the histopathological diagnosis of systemic vasculitides in daily practice?
Honsová E
Cesk Patol; 2020; 56(2):68-73. PubMed ID: 32493022
[TBL] [Abstract][Full Text] [Related]
24. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.
Hruskova Z; Stel VS; Jayne D; Aasarød K; De Meester J; Ekstrand A; Eller K; Heaf JG; Hoitsma A; Martos Jimenéz C; Ravani P; Wanner C; Tesar V; Jager KJ
Am J Kidney Dis; 2015 Oct; 66(4):613-20. PubMed ID: 25975963
[TBL] [Abstract][Full Text] [Related]
26. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides.
Zhang W; Zhou G; Shi Q; Zhang X; Zeng XF; Zhang FC
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S65-9. PubMed ID: 19646349
[TBL] [Abstract][Full Text] [Related]
27. ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients.
Cornec D; Cornec-Le Gall E; Fervenza FC; Specks U
Nat Rev Rheumatol; 2016 Oct; 12(10):570-9. PubMed ID: 27464484
[TBL] [Abstract][Full Text] [Related]
28. Granulomatous Vasculitis.
Sharma A; Dogra S; Sharma K
Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
[TBL] [Abstract][Full Text] [Related]
29. ANCA-associated vasculitis in childhood: recent advances.
Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
[TBL] [Abstract][Full Text] [Related]
30. The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 266 AAV patients.
Arnold S; Wallmeier P; Tais A; Ihorst G; Janoschke M; Schubach F; Aries P; Bergner R; Bremer JP; Görl N; Gutdeutsch E; Hellmich B; Henes J; Hoyer BF; Kangowski A; Kötter I; Krusche M; Magnus T; Metzler C; Müller-Ladner U; Petersen J; Reichelt de Tenorio A; Schaier M; Schirmer JH; Schönermarck U; Thiel J; Unger L; Venhoff N; Weinmann-Menke J; Iking-Konert C; Lamprecht P
Clin Exp Rheumatol; 2024 Apr; 42(4):852-858. PubMed ID: 38607682
[TBL] [Abstract][Full Text] [Related]
31. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
[TBL] [Abstract][Full Text] [Related]
32. New advances in the pathogenesis of ANCA-associated vasculitides.
Chen M; Kallenberg CG
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
[TBL] [Abstract][Full Text] [Related]
33. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.
Arulkumaran N; Periselneris N; Gaskin G; Strickland N; Ind PW; Pusey CD; Salama AD
Rheumatology (Oxford); 2011 Nov; 50(11):2035-43. PubMed ID: 21873269
[TBL] [Abstract][Full Text] [Related]
34. [Cortisone-free rheumatology-Vasculitides].
Holle JU; Moosig F
Z Rheumatol; 2021 May; 80(4):314-321. PubMed ID: 33709164
[TBL] [Abstract][Full Text] [Related]
35. Treatment of ANCA-associated systemic vasculitis.
Belmont HM
Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases.
Sreih AG; Annapureddy N; Springer J; Casey G; Byram K; Cruz A; Estephan M; Frangiosa V; George MD; Liu M; Parker A; Sangani S; Sharim R; Merkel PA;
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1368-1374. PubMed ID: 27804171
[TBL] [Abstract][Full Text] [Related]
37. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
38. An update on dıagnosıs and treatment of ANCA assocıated renal vasculıtıs.
Turkmen K; Ozer H; Tesar V
Int Urol Nephrol; 2023 Nov; 55(11):2817-2827. PubMed ID: 37010734
[TBL] [Abstract][Full Text] [Related]
39. How best to manage relapse and remission in ANCA-associated vasculitis.
Puéchal X; Guillevin L
Expert Rev Clin Immunol; 2022 Nov; 18(11):1135-1143. PubMed ID: 36102147
[TBL] [Abstract][Full Text] [Related]
40. Use of methotrexate in ANCA-associated vasculitides.
Reinhold-Keller E; de Groot K
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S178-82. PubMed ID: 21044456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
